![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, June 12, 2018 11:00:03 AM
All else is truthful. The company contacted the Boston Business Journal and invited Don Seiffert to Beverly after one of the MAKO hit pieces and published an article in The BBJ on 8/16/15. An excerpt from that arrticle:
"Ehrlich — who calls the entire blog post a “lie” and a “fraud” — contacted me after I wrote a short blog on the matter earlier this week. He invited me to come out to Beverly to see the company first-hand, and I took him up on the offer. I had spoken to Ehrlich by phone a few times over the past two years but had never met him in person."
Seems Mr. Seiffert had spoken to LE "a few times over the past two years" prior to his 8/2015 visit
The article:
https://www.bizjournals.com/boston/blog/bioflash/2015/08/my-visit-to-cellceutix-the-biotech-that-a-short.html
I've contacted the BBJ keeping them up to with the company's progress via attaching the company pr's (started in early February 2018 attaching ipix 1/29/pr and some other pr's since. No response.
Here's the email first I sent to BBJ:
Hi Mr. Seiffert,
A few years back you did a story on a company based in Beverly, MA named Cellceutix(name changed last year to Innovation Pharmaceutical) (https://www.bizjournals.com/boston/ blog/bioflash/2015/08/my-visit-to-cellceutix-the-biotech-that-a-short.html).
Though their share price never recovered, their trials have succeeded with final phase 2b results for their drugs, Prurisol, to treat moderate to severe psoriasis, and Brilacidin, to treat oral mucositis , both due out any time this quarter..
Here is their most recent pr(1/29/18).
http://www.ipharminc.com/press-release/2018/1/29/innovation-pharmaceuticals-brilacidin-franchise-anchored-in-three-clinical-indications-oral-mucositis-inflammatory-bowel-disease-and-serious-skin-infections-expands-into-dermatologic-diseases
Any chance you could do a follow- up story?
Thanks,
xxx xxxxx
As ceo, cfo, receptionist, and investor contact(pr guy) he's juggling too much in my ipinion. He could easily, I would think, cut his own salary by $1000 per week and hire an office manager like a majority of similiar. I've also suggested he contact BBJ again, as well as the Boston Globe or Herald.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM